trial · primary record
Niraparib
Castration-Resistant Prostatic Cancer
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 765 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Cohort 1: Radiographic Progression-Free Survival (rPFS) as Assessed by Blinded Independent Central Review (BICR) |
| Registry ID | NCT03748641 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:48.468Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03748641
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Niraparib · compound